These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34247192)

  • 21. The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
    Sinnamon AJ; Sharon CE; Song Y; Neuwirth MG; Elder DE; Xu X; Chu EY; Ming ME; Fraker DL; Gimotty PA; Karakousis GC
    J Am Acad Dermatol; 2018 Aug; 79(2):245-251. PubMed ID: 29518458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas.
    Skochdopole AJ; Kutlu OC; Engelhardt KE; Lancaster WP; Abbott AM; Camp ER
    J Surg Res; 2020 Dec; 256():198-205. PubMed ID: 32711176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node status affects long-term survival in patients with intermediate-thickness melanoma.
    G Lben K; Berberoğlu U; Altınyollar H; Kınaş V; Turanlı S
    J Cancer Res Ther; 2016; 12(2):840-4. PubMed ID: 27461661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm).
    Holmberg CJ; Mikiver R; Isaksson K; Ingvar C; Moncrieff M; Nielsen K; Ny L; Lyth J; Olofsson Bagge R
    Ann Surg Oncol; 2023 Dec; 30(13):8026-8033. PubMed ID: 37574516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
    Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
    Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
    Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to Procedure, Nuclear Imaging and Clinicopathological Characteristics as Predictive Factors for Sentinel Lymph Node Metastasis in Cutaneous Melanoma: A Single-Center Analysis.
    Jaukovic L; Rajović M; Kandolf Sekulovic L; Radulovic M; Stepic N; Mijuskovic Z; Petrov N; Ajdinovic B
    Ann Plast Surg; 2018 Jul; 81(1):80-86. PubMed ID: 29762449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.
    Tas F; Erturk K
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2721-2729. PubMed ID: 33611652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma.
    Kretschmer L; Mitteldorf C; Hellriegel S; Leha A; Fichtner A; Ströbel P; Schön MP; Bremmer F
    Mod Pathol; 2021 Oct; 34(10):1839-1849. PubMed ID: 34131294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macroscopic tumor dimension, sentinel lymph node outcome, and survival analysis among cutaneous melanoma.
    Asato MA; Moraes-Neto FA; Moraes MPT; Ocanha-Xavier JP; Alencar Marques ME; Xavier-Junior JCC
    Int J Dermatol; 2024 Jun; 63(6):765-772. PubMed ID: 38217520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.
    Sun W; Xu Y; Yang J; Liao Z; Li T; Huang K; Patel P; Yan W; Chen Y
    Cancer Commun (Lond); 2020 Nov; 40(11):586-597. PubMed ID: 33025763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node biopsy for 102 patients with primary cutaneous melanoma at a single Japanese institute.
    Otsuka M; Yamasaki O; Kaji T; Iwatsuki K; Asagoe K
    J Dermatol; 2015 Oct; 42(10):954-61. PubMed ID: 26074328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?
    Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS
    Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
    Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
    Eur J Surg Oncol; 2020 Feb; 46(2):263-271. PubMed ID: 31594672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.